Summary of STERIS plc (NYSE:STE) Ratings on May 17, 2018

May 17, 2018 - By Lindsey Price

STERIS plc (NYSE:STE) Corporate Logo
During 2017 Q4 the big money sentiment decreased to 0.17. That’s change of 0.33, from 2017Q3’s 0.5. 4 investors sold all, 2 reduced holdings as STERIS plc ratio worsened. 0 increased positions while 1 funds bought positions. Funds hold 19,649 shares thus 85.67% less from 2017Q3’s 137,131 shares.
Moreover, Alphamark Ltd has 0.01% invested in STERIS plc (NYSE:STE) for 150 shs. 14,076 were reported by Fruth. Shine Advisory Services holds 0.01% or 123 shs. Hanson Doremus Inv has 0.04% invested in STERIS plc (NYSE:STE). Prudential Public Ltd Com reported 3,800 shs stake.

STERIS plc (NYSE:STE) Ratings Coverage

In total 3 analysts cover STERIS (NYSE:STE). “Buy” rating has 2, “Sell” are 0, while 1 are “Hold”. 67% are bullish. 3 are the (NYSE:STE)’s analyst reports since January 3, 2018 according to StockzIntelligence Inc. On Wednesday, January 3 the stock has “Market Perform” rating by Raymond James. In Thursday, February 8 report KeyBanc Capital Markets maintained the stock with “Buy” rating. On Thursday, February 8 the rating was maintained by Northcoast with “Buy”. Listed here are STERIS plc (NYSE:STE) PTs and latest ratings.

08/02/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $103.0 Maintain
08/02/2018 Broker: Northcoast Rating: Buy New Target: $102.0 Maintain
03/01/2018 Broker: Raymond James Old Rating: Outperform New Rating: Market Perform Old Target: $100 Downgrade

Ticker’s shares touched $103.28 during the last trading session after 0.35% change.STERIS plc has volume of 302,150 shares. Since May 17, 2017 STE has risen 32.31% and is uptrending. The stock outperformed the S&P 500 by 20.76%.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide.The firm is valued at $8.76 billion. The companyÂ’s Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.The P/E ratio is 36.38. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

There’s a significant STERIS plc (NYSE:STE) news posted by Seekingalpha.com. It’s an article titled: “STERIS Plc (STE) Q4 2018 Results – Earnings Call Transcript” on May 09, 2018.

STERIS plc (NYSE:STE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.